FindTrial
Sign In

Amdinistration of Amalaki Churna as Rasayana and Its Free Radicals Scavenging Activity In Healthy Individuals.

Evaluation of Oushadha Sevan Kala of Amalaki Churna( Emblica officinalis Gaertn.) as Rasayana and Its Free Radicals Scavenging Activity In Healthy Individuals.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/10/015953
Enrollment
120
Registered
2018-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Amalaki Churna: Drug - amalaki churna Dose - 3gms Route of administration - oral Duration of therapy - 30 days Intervention2: Amalaki Churna: Dose - 3 gms Route of Administration - Oral

Sponsors

Parul University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy Individuals will be Selected

Exclusion criteria

Exclusion criteria: The Individuals Suffering From Chronic Diseases, Congenital Abnormalities and any other Life Style Disorders

Design outcomes

Primary

MeasureTime frame
Evaluation of Free Radical Scavenging Activity of Amalaki Churna on Healthy IndividualsTimepoint: 30 Days—

Secondary

MeasureTime frame
Boost immune system of the bodyTimepoint: 30 days—

Countries

India

Contacts

Public ContactDr Satej Tippanna Banne

Parul University

drhemantt@gmail.com8469496525

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026